Clinical trials
Observational Dysbiosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 9 |
| Unknown status | 6 |
| Active, not recruiting | 4 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 2 |
| Igenomix | 2 |
| University Hospital, Lille | 2 |
| Aydin Adnan Menderes University | 1 |
| Bernardino Clavo, MD, PhD | 1 |
| Centre Hospitalier Universitaire de la Guadeloupe | 1 |
| Centre Hospitalier de Cayenne | 1 |
| Centre National de la Recherche Scientifique, France | 1 |
| Cho Yoon soo | 1 |
| Clinical Hospital Center Rijeka | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dysbiosis | 48 |
| Periodontitis | 5 |
| Crohn Disease | 3 |
| Inflammation | 3 |
| Inflammatory Bowel Diseases | 3 |
| Obesity | 3 |
| Periodontal Diseases | 3 |
| Arthritis, Rheumatoid | 2 |
| Chronic Periodontitis | 2 |
| Colorectal Neoplasms | 2 |
Trials
Showing 26 to 48 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.